SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-17-004362
Filing Date
2017-11-15
Accepted
2017-11-15 16:32:06
Documents
1
Period of Report
2017-11-13

Document Format Files

Seq Description Document Type Size
1 HILLHOUSE CAPITAL MANAGEMENT, LTD. p17-2141form4.html 4  
1 HILLHOUSE CAPITAL MANAGEMENT, LTD. p17-2141form4.xml 4 9473
  Complete submission text file 0000902664-17-004362.txt   11326
Mailing Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014
Business Address 6400 WESTWIND WAY SUITE A CRESTWOOD KY 40014 502-241-4114
Apellis Pharmaceuticals, Inc. (Issuer) CIK: 0001492422 (see all company filings)

IRS No.: 271537290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address DMS HOUSE, 20 GENESIS CLOSE GEORGE TOWN, GRAND CAYMAN E9 00000
Business Address DMS HOUSE, 20 GENESIS CLOSE GEORGE TOWN, GRAND CAYMAN E9 00000 345 749 8642
Hillhouse Capital Management, Ltd. (Reporting) CIK: 0001510589 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38276 | Film No.: 171205554